{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:56Z","timestamp":1792636736628,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangxi Provincial Graduate Student Innovation Special Fund","award":["YC2025-B184"],"award-info":[{"award-number":["YC2025-B184"]}]},{"name":"National Natural Science Foundation of China Regional Program","award":["82260131 and 82460128"],"award-info":[{"award-number":["82260131 and 82460128"]}]},{"name":"Key Program of Jiangxi Provincial Natural Science Foundation","award":["20212ACB206017"],"award-info":[{"award-number":["20212ACB206017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04843-y","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T16:03:47Z","timestamp":1785081827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactobacillus mucosae extracellular vesicles improve metabolic dysfunction-associated fatty liver disease by activating the AMPK pathway via the gut-liver axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Kaige","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-8536","authenticated-orcid":false,"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"4843_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"4843_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69:896\u2013904.","journal-title":"J Hepatol"},{"key":"4843_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S32\u201350.","journal-title":"Clin Mol Hepatol"},{"key":"4843_CR4","doi-asserted-by":"publisher","first-page":"1365294","DOI":"10.3389\/fphar.2024.1365294","volume":"15","author":"Z Ming","year":"2024","unstructured":"Ming Z, Ruishi X, Linyi X, Yonggang Y, Haoming L, Xintian L. The gut-liver axis in fatty liver disease: role played by natural products. Front Pharmacol. 2024;15:1365294.","journal-title":"Front Pharmacol"},{"key":"4843_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","volume":"67","author":"R Wiest","year":"2017","unstructured":"Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R. Targeting the gut-liver axis in liver disease. J Hepatol. 2017;67:1084\u2013103.","journal-title":"J Hepatol"},{"key":"4843_CR6","doi-asserted-by":"publisher","unstructured":"Schnabl B, Damman CJ, Carr RM. Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. J Clin Invest. 2025;135(7):e186423. https:\/\/doi.org\/10.1172\/JCI186423","DOI":"10.1172\/JCI186423"},{"key":"4843_CR7","doi-asserted-by":"publisher","first-page":"e13646","DOI":"10.1111\/obr.13646","volume":"25","author":"X Su","year":"2024","unstructured":"Su X, Chen S, Liu J, Feng Y, Han E, Hao X, et al. Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Obes Rev. 2024;25:e13646.","journal-title":"Obes Rev"},{"key":"4843_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4843_CR9","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1039\/D4FO02561J","volume":"15","author":"S Ding","year":"2024","unstructured":"Ding S, Hong Q, Yao Y, Gu M, Cui J, Li W, et al. Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients. Food Funct. 2024;15:9954\u201371.","journal-title":"Food Funct"},{"key":"4843_CR10","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.3350\/cmh.2024.0811","volume":"31","author":"H Saeed","year":"2025","unstructured":"Saeed H, D\u00edaz LA, Gil-G\u00f3mez A, Burton J, Bajaj JS, Romero-Gomez M, et al. Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S94\u2013111.","journal-title":"Clin Mol Hepatol"},{"key":"4843_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12602-016-9244-8","volume":"9","author":"GMD de Moraes","year":"2017","unstructured":"de Moraes GMD, de Abreu LR, do Egito AS, Salles HO, da Silva LMF, Nero LA, et al. Functional properties of Lactobacillus mucosae strains isolated from Brazilian goat milk. Probiotics Antimicrob Proteins. 2017;9:235\u201345.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4843_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ygeno.2017.12.009","volume":"111","author":"VDV Valeriano","year":"2019","unstructured":"Valeriano VDV, Oh JK, Bagon BB, Kim H, Kang DK. Comparative genomic analysis of Lactobacillus mucosae LM1 identifies potential niche-specific genes and pathways for gastrointestinal adaptation. Genomics. 2019;111:24\u201333.","journal-title":"Genomics"},{"issue":"24","key":"4843_CR13","doi-asserted-by":"publisher","first-page":"fnz254","DOI":"10.1093\/femsle\/fnz254","volume":"366","author":"J Jiang","year":"2019","unstructured":"Jiang J, Feng N, Zhang C, Liu F, Zhao J, Zhang H, et al. Lactobacillus reuteri A9 and Lactobacillus mucosae A13 isolated from Chinese superlongevity people modulate lipid metabolism in a hypercholesterolemia rat model. FEMS Microbiol Lett. 2019;366(24):fnz254.","journal-title":"FEMS Microbiol Lett."},{"key":"4843_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8081225","author":"T Jiang","year":"2020","unstructured":"Jiang T, Wu H, Yang X, Li Y, Zhang Z, Chen F, et al. Lactobacillus mucosae strain promoted by a high-fiber diet in genetic obese child alleviates lipid metabolism and modifies gut microbiota in ApoE(-\/-) mice on a Western diet. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8081225.","journal-title":"Microorganisms"},{"key":"4843_CR15","doi-asserted-by":"publisher","first-page":"100216","DOI":"10.1016\/j.mocell.2025.100216","volume":"48","author":"LN Qin","year":"2025","unstructured":"Qin LN, Yu YF, Ma L, Yu R. Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics. Mol Cells. 2025;48:100216.","journal-title":"Mol Cells"},{"key":"4843_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3389\/fmicb.2019.02155","volume":"10","author":"F Ashrafian","year":"2019","unstructured":"Ashrafian F, Shahriary A, Behrouzi A, Moradi HR, KeshavarzAziziRaftar S, Lari A, et al. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front Microbiol. 2019;10:2155.","journal-title":"Front Microbiol"},{"key":"4843_CR17","doi-asserted-by":"publisher","first-page":"e0048421","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"SKA Raftar","year":"2021","unstructured":"Raftar SKA, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, et al. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr. 2021;9:e0048421.","journal-title":"Microbiol Spectr"},{"key":"4843_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/hep.32608","volume":"77","author":"M Jiang","year":"2023","unstructured":"Jiang M, Li F, Liu Y, Gu Z, Zhang L, Lee J, et al. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. Hepatology. 2023;77:1164\u201380.","journal-title":"Hepatology"},{"key":"4843_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep4.1679","volume":"5","author":"Z Gu","year":"2021","unstructured":"Gu Z, Li F, Liu Y, Jiang M, Zhang L, He L, et al. Exosome-like nanoparticles from Lactobacillus rhamnosus GG protect against alcohol-associated liver disease through intestinal aryl hydrocarbon receptor in mice. Hepatol Commun. 2021;5:846\u201364.","journal-title":"Hepatol Commun"},{"key":"4843_CR20","first-page":"955","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Yang RX, Nan YM, Wei L, Jia JD, et al. Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024). J Clin Transl Hepatol. 2024;12:955\u201374.","journal-title":"J Clin Transl Hepatol"},{"key":"4843_CR21","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.crfs.2022.09.022","volume":"5","author":"H Pan","year":"2022","unstructured":"Pan H, Zhou M, Ju Z, Luo J, Jin J, Shen L, et al. Potential role of gut microbiota-LCA-INSR axis in high fat-diet-induced non-alcoholic fatty liver dysfunction: from perspective of radiation variation. Curr Res Food Sci. 2022;5:1685\u2013700.","journal-title":"Curr Res Food Sci"},{"key":"4843_CR22","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1038\/srep32002","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B, Jiang X, Cao M, Ge J, Bao Q, Tang L, et al. Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci Rep. 2016;6:32002.","journal-title":"Sci Rep"},{"key":"4843_CR23","doi-asserted-by":"publisher","first-page":"2351620","DOI":"10.1080\/19490976.2024.2351620","volume":"16","author":"J Wei","year":"2024","unstructured":"Wei J, Luo J, Yang F, Feng X, Zeng M, Dai W, et al. Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine. Gut Microbes. 2024;16:2351620.","journal-title":"Gut Microbes"},{"key":"4843_CR24","first-page":"100496","volume":"9","author":"Y Nami","year":"2025","unstructured":"Nami Y, ShaghaghiRanjbar M, Modarres Aval M, Haghshenas B. Harnessing Lactobacillus-derived SCFAs for food and health: pathways, genes, and functional implications. Curr Res Microb Sci. 2025;9:100496.","journal-title":"Curr Res Microb Sci"},{"key":"4843_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12122488","author":"T Olotu","year":"2024","unstructured":"Olotu T, Ferrell JM. Lactobacillus sp. for the attenuation of metabolic dysfunction-associated steatotic liver disease in mice. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12122488.","journal-title":"Microorganisms"},{"key":"4843_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12934-020-1289-4","volume":"19","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact. 2020;19:23.","journal-title":"Microb Cell Fact"},{"key":"4843_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro2297","volume":"8","author":"S Lebeer","year":"2010","unstructured":"Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8:171\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"4843_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12951-024-02979-3","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, Shi M, Wang Y, Liu J, Liu S, Kang W, et al. Probiotic-derived extracellular vesicles alleviate AFB1-induced intestinal injury by modulating the gut microbiota and AHR activation. J Nanobiotechnology. 2024;22:697.","journal-title":"J Nanobiotechnology"},{"key":"4843_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.31083\/j.fbl2907241","volume":"29","author":"B Li","year":"2024","unstructured":"Li B, Chi X, Huang Y, Wang W, Liu Z. Bifidobacterium longum-derived extracellular vesicles prevent hepatocellular carcinoma by modulating the TGF-\u03b21\/Smad signaling in mice. Front Biosci (Landmark Ed). 2024;29:241.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4843_CR30","doi-asserted-by":"publisher","first-page":"102781","DOI":"10.1016\/j.xcrm.2026.102781","volume":"7","author":"J Xie","year":"2026","unstructured":"Xie J, Dai XJ, Li Q, Zhang W, Nie X, Ji H, et al. Escherichia coli Nissle 1917 alleviates Alzheimer\u2019s disease in mice through OmpA-containing outer membrane vesicles. Cell Rep Med. 2026;7:102781.","journal-title":"Cell Rep Med"},{"key":"4843_CR31","doi-asserted-by":"publisher","first-page":"19259","DOI":"10.1021\/acs.jafc.4c04223","volume":"72","author":"X Chen","year":"2024","unstructured":"Chen X, Li Q, Xie J, Nie S. Immunomodulatory effects of probiotic-derived extracellular vesicles: opportunities and challenges. J Agric Food Chem. 2024;72:19259\u201373.","journal-title":"J Agric Food Chem"},{"key":"4843_CR32","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI29044","volume":"116","author":"YC Long","year":"2006","unstructured":"Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776\u201383.","journal-title":"J Clin Invest"},{"key":"4843_CR33","doi-asserted-by":"publisher","first-page":"1558041","DOI":"10.3389\/fimmu.2025.1558041","volume":"16","author":"J Feng","year":"2025","unstructured":"Feng J, MengHuan L, TingTing Y, XueJie Y, HaiNing G. Research progress on AMPK in the pathogenesis and treatment of MASLD. Front Immunol. 2025;16:1558041.","journal-title":"Front Immunol"},{"key":"4843_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12951-025-03435-6","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang Y, E Q, Naveed M, Wang X, Liu Y, et al. The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication. J Nanobiotechnology. 2025;23:349.","journal-title":"J Nanobiotechnology."},{"key":"4843_CR35","doi-asserted-by":"publisher","first-page":"11757","DOI":"10.1039\/D4FO04194A","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Li M, Fang X, Yu D, Hu X. Dietary Lactobacillus johnsonii-derived extracellular vesicles ameliorate acute colitis by regulating gut microbiota and maintaining intestinal barrier homeostasis. Food Funct. 2024;15:11757\u201379.","journal-title":"Food Funct"},{"key":"4843_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12934-021-01709-w","volume":"20","author":"F Ashrafian","year":"2021","unstructured":"Ashrafian F, Raftar SKA, Lari A, Shahryari A, Abdollahiyan S, Moradi HR, et al. Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice. Microb Cell Fact. 2021;20:219.","journal-title":"Microb Cell Fact."},{"key":"4843_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","volume":"65","author":"MC Dao","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426\u201336.","journal-title":"Gut"},{"key":"4843_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14111284","author":"P Yang","year":"2025","unstructured":"Yang P, Wu M, Liang W, Sun Y, Pan LL, Sun J. Allobaculum mucilyticum-mediated gut barrier dysfunction exacerbates the severity of hypertriglyceridemic acute pancreatitis in mice. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14111284.","journal-title":"Antioxidants"},{"key":"4843_CR39","doi-asserted-by":"publisher","first-page":"1098386","DOI":"10.3389\/fmicb.2023.1098386","volume":"14","author":"MF Maciel-Fiuza","year":"2023","unstructured":"Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR, et al. Role of gut microbiota in infectious and inflammatory diseases. Front Microbiol. 2023;14:1098386.","journal-title":"Front Microbiol"},{"key":"4843_CR40","doi-asserted-by":"publisher","first-page":"21829","DOI":"10.1038\/s41598-020-78920-z","volume":"10","author":"SS Bajic","year":"2020","unstructured":"Bajic SS, Ca\u00f1as MA, Tolinacki M, Badia J, S\u00e1nchez B, Golic N, et al. Proteomic profile of extracellular vesicles released by Lactiplantibacillus plantarum BGAN8 and their internalization by non-polarized HT29 cell line. Sci Rep. 2020;10:21829.","journal-title":"Sci Rep"},{"key":"4843_CR41","doi-asserted-by":"publisher","first-page":"19237","DOI":"10.1038\/s41598-020-75930-9","volume":"10","author":"C B\u00e4uerl","year":"2020","unstructured":"B\u00e4uerl C, Coll-Marqu\u00e9s JM, Tarazona-Gonz\u00e1lez C, P\u00e9rez-Mart\u00ednez G. Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface. Sci Rep. 2020;10:19237.","journal-title":"Sci Rep"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04843-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:58:03Z","timestamp":1792634283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4843"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04843-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study involving human participants was approved by the Biomedical Research Ethics Committee of the Second Affiliated Hospital of Nanchang University (Clinical Ethics No. O-Medical Research Ethics-2025\u2013019), with written informed consent and adherence to the Declaration of Helsinki and WHO guidelines, while all animal procedures were approved and supervised by the Animal Ethics and Welfare Committee of Nanchang University (Animal Ethics No. NCULAE-20241023001).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"979"}}